Institution profile

医療法人Nクリニック 本町Nクリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02E2508013 +3

Location

Prefecture
Osaka
Address
大阪市西区西本町一丁目4番1号オリックス本町ビル2階

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 医療法人社団優恵会特定認定再生医療等委員会

Public score

60.0/ 100

A · Review level
25.0 / 30
B · Technologies
18.5 / 35
C · Coverage
10.7 / 25
D · Class I / II technologies
5.8 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 60.0
Public score →100

Registered technologies (4)

Stem cells (all sources) 2
Registered technologies · Japanese originalTechnology areasPlan classification
脂肪幹細胞を用いた変形性関節症に対する再生医療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
脂肪由来間葉系間質細胞を用いた腱板、腱、靭帯、筋および周辺組織の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
Adipose-derived stem cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
脂肪幹細胞を用いた変形性関節症に対する再生医療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
脂肪由来間葉系間質細胞を用いた腱板、腱、靭帯、筋および周辺組織の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
PRP and platelet-derived 2
Registered technologies · Japanese originalTechnology areasPlan classification
変形性関節症に対する多血小板血漿を用いた再生医療PRP and platelet-derivedJoints and musculoskeletalClass II
多血小板血漿を用いた腱板、筋、腱および周辺組織の治療PRP and platelet-derivedJoints and musculoskeletalClass III
Joints and musculoskeletal 4
Registered technologies · Japanese originalTechnology areasPlan classification
脂肪幹細胞を用いた変形性関節症に対する再生医療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
脂肪由来間葉系間質細胞を用いた腱板、腱、靭帯、筋および周辺組織の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
変形性関節症に対する多血小板血漿を用いた再生医療PRP and platelet-derivedJoints and musculoskeletalClass II
多血小板血漿を用いた腱板、筋、腱および周辺組織の治療PRP and platelet-derivedJoints and musculoskeletalClass III

Certified committee for regenerative medicine

  • 医療法人社団優恵会特定認定再生医療等委員会

Public document number

  • 02E2508013
  • 02E2508014
  • 01E2510012
  • 02E2508015
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
脂肪幹細胞を用いた変形性関節症に対する再生医療Class II医療法人社団優恵会特定認定再生医療等委員会02E2508013
変形性関節症に対する多血小板血漿を用いた再生医療Class II医療法人社団優恵会特定認定再生医療等委員会02E2508014
脂肪由来間葉系間質細胞を用いた腱板、腱、靭帯、筋および周辺組織の治療Class II医療法人社団優恵会特定認定再生医療等委員会01E2510012
多血小板血漿を用いた腱板、筋、腱および周辺組織の治療Class III医療法人社団優恵会特定認定再生医療等委員会02E2508015

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor